Results 191 to 200 of about 11,242 (227)
A Novel Method for Prognostic Risk Classification After Carbon-Ion Radiotherapy for Hepatocellular Carcinoma Using Data-Mining Methods. [PDF]
Hayashi K +9 more
europepmc +1 more source
Treatment Outcomes in Patients Receiving Carbon-Ion Radiotherapy Versus Hepatectomy for Hepatocellular Carcinoma (≥4 cm): A Retrospective Study in Japan. [PDF]
Maki K +9 more
europepmc +1 more source
SUPERCONDUCTING GANTRY FOR CARBON-ION RADIOTHERAPY
openaire
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Indications for Carbon Ion Radiotherapy
Clinical Oncology, 2018Compared with photon and proton therapy, carbon ion radiotherapy (CIRT) offers potentially superior dose distributions, which may permit dose escalation with the potential for improved sparing of adjacent normal tissues. CIRT has increased biological effectiveness leading to increased tumour killing compared with other radiation modalities.
Mohamad, O., Yamada, S., Durante, M.
openaire +3 more sources
Carbon Ion Radiotherapy for Skull Base Chordoma [PDF]
To present the results of the clinical study of carbon ion radiotherapy (CIRT) for skull base and paracervical spine tumors at the National Institute of Radiological Sciences in Chiba, Japan.The study is comprised of three protocols: a pilot study, a phase I/II dose escalation study, and a phase II study.
Hirohiko Tsujii +2 more
exaly +3 more sources
Radiotherapy with beams of carbon ions
Reports on Progress in Physics, 2005In cancer treatment, the introduction of MeV bremsstrahlung photons has been instrumental in delivering higher doses to deep-seated tumours, while reducing the doses absorbed by the surrounding healthy tissues. Beams of protons and carbon ions have a much more favourable dose-depth distribution than photons (called ‘x-rays’ by medical doctors) and are ...
Ugo Amaldi, Gerhard Kraft
openaire +1 more source
Carbon Ion Radiotherapy for Unresectable Retroperitoneal Sarcomas
International Journal of Radiation Oncology*Biology*Physics, 2009To evaluate the applicability of carbon ion radiotherapy (CIRT) for unresectable retroperitoneal sarcomas with regard to normal tissue morbidity and local tumor control.From May 1997 to February 2006, 24 patients (17 male and 7 female) with unresectable retroperitoneal sarcoma received CIRT. Age ranged from 16 to 77 years (median, 48.6 years).
Itsuko, Serizawa +8 more
openaire +2 more sources
Carbon ion radiotherapy in the treatment of gliomas: a review
Journal of Neuro-Oncology, 2019Gliomas are among the most common primary brain malignancies, with a poor prognosis for high grade gliomas despite aggressive therapy. Carbon ions, which exhibit favorable biological and physical characteristics, have recently been studied in intracranial malignancies as a way to escalate dose to the tumor while minimizing dose to normal tissue.Pubmed ...
Timothy D. Malouff +3 more
openaire +2 more sources
Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer
Pancreas, 2020Abstract Pancreatic cancer is the fourth most common cause of cancer-related morality worldwide, and the prognosis remains poor despite aggressive therapy. Carbon ion radiotherapy has favorable radiobiological and physical characteristics in the treatment, including a higher linear energy transfer and higher relative biological effectiveness,
Timothy D, Malouff +7 more
openaire +2 more sources
Results of carbon ion radiotherapy in 152 patients
International Journal of Radiation Oncology*Biology*Physics, 2004This study summarizes the experience with raster scanned carbon ion radiation therapy (RT) at the Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany since 1997.Between December 1997 and December 2002, 152 patients were treated at GSI with carbon ion RT.
Daniela, Schulz-Ertner +8 more
openaire +2 more sources

